EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan

Yang-Chuan Chen iD, Min-Chi Cheng, Po-Huang Chen iD, Chi-Hsiang Chung iD, Wu-Chien Chien, Ming-Shen Dai, Jia-Hong Chen, Tzu-Chuan Huang

Breast Cancer: Targets and Therapy · 2026-06 · Volume 18 · 1-14

DOI: 10.2147/bctt.s595563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-06. Verfasst von Yang-Chuan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

breast cancercardiotoxicityepirubicinoverall survivalpegylated liposomal doxorubicin

Autor:innen und Institutionen

  • Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Department of Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Department of Medical Research, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Graduate Institute of Public Health, College of Public Health, National Defense Medical University, Taipei, Taiwan.
  • Taiwanese Injury Prevention and Safety Promotion Association (TIPSPA), Taipei, Taiwan.

ORCID-Profile: Yang-Chuan Chen, Po-Huang Chen, Chi-Hsiang Chung

Zitieren

APA

Chen, Y. C., Cheng, M. C., Chen, P. H., Chung, C. H., Chien, W. C., Dai, M. S., Chen, J. H., & Huang, T. C. (2026). Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. Breast Cancer: Targets and Therapy, Volume 18, 1-14. https://doi.org/10.2147/bctt.s595563

Vancouver

Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, et al. Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-14. doi:10.2147/bctt.s595563

BibTeX
@article{Chen2026,
  author = {Chen, Yang-Chuan and Cheng, Min-Chi and Chen, Po-Huang and Chung, Chi-Hsiang and Chien, Wu-Chien and Dai, Ming-Shen and Chen, Jia-Hong and Huang, Tzu-Chuan},
  title = {Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--14},
  doi = {10.2147/bctt.s595563}
}
Kostenlos starten →